Stocksigma LogoStocksigma Logo

Suven Life Sciences Board Meeting on 5th Nov'26 to Consider Q2 Results

Suven Life Sciences Limited has scheduled a Board of Directors meeting for 5th Nov'26 to consider and approve the standalone and consolidated unaudited

Suven Life Sciences Board Meeting on 5th Nov'26 to Consider Q2 Results

Suven Life Sciences Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Suven Life Sciences Board Meeting on 5th Nov'26 to Consider Q2 Results Suven Life Sciences Limited has scheduled a Board of Directors meeting for 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain closed until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Suven Life Sciences Ltd

All Suven Life Sciences Ltd announcements